Publications

  1. Skibola CF, Berndt SI, Vijai J, Conde L, Wang Z, Yeager M, de Bakker PI, Birmann BM, Vajdic CM, Foo JN, Bracci PM, Vermeulen RC, Slager SL, de Sanjose S, Wang SS, Linet MS, Salles G, Lan Q, Severi G, Hjalgrim H, Lightfoot T, Melbye M, Gu J, Ghesquieres Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region. Am J Hum Genet. 2014 Oct 2; 95(4):462-71.
    View PubMed
  2. Cerhan JR, Berndt SI, Vijai J, Ghesquieres H, McKay J, Wang SS, Wang Z, Yeager M, Conde L, de Bakker PI, Nieters A, Cox D, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Lan Q, Severi G, Melbye M, Gu J, Jackson RD, Kane E, Teras LR, Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet. 2014 Sep 28.
    View PubMed
  3. Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjose S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):130-44.
    View PubMed
  4. Tilburt JC, Wynia MK, Montori VM, Thorsteinsdottir B, Egginton JS, Sheeler RD, Liebow M, Humeniuk KM, Goold SD. Shared decision-making as a cost-containment strategy: US physician reactions from a cross-sectional survey. BMJ Open. 2014; 4(1):e004027. Epub 2014 Jan 14.
    View PubMed
  5. Antiel RM, James KM, Egginton JS, Sheeler RD, Liebow M, Goold SD, Tilburt JC. Specialty, political affiliation, and perceived social responsibility are associated with U.S. physician reactions to health care reform legislation. J Gen Intern Med. 2014; 29(2):399-403.
  6. Olson JE, Ryu E, Johnson KJ, Koenig BA, Maschke KJ, Morrisette JA, Liebow M, Takahashi PY, Fredericksen ZS, Sharma RG, Anderson KS, Hathcock MA, Carnahan JA, Pathak J, Lindor NM, Beebe TJ, Thibodeau SN, Cerhan JR. The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin Proc. 2013 Sep; 88(9):952-62.
    View PubMed
  7. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013 Aug; 45(8):868-76. Epub 2013 Jun 16.
    View PubMed
  8. Tilburt JC, Wynia MK, Sheeler RD, Thorsteinsdottir B, James KM, Egginton JS, Liebow M, Hurst S, Danis M, Goold SD. Views of US physicians about controlling health care costs. JAMA. 2013 Jul 24; 310(4):380-8.
    View PubMed
  9. Antiel RM, James KM, Egginton JS, Sheeler RD, Liebow M, Goold SD, Tilburt JC. Specialty, Political Affiliation, and Perceived Social Responsibility Are Associated with U.S. Physician Reactions to Health Care Reform Legislation. J Gen Intern Med. 2013 Jun 25.
    View PubMed
  10. Charbonneau B, O'Connor HM, Wang AH, Liebow M, Thompson CA, Fredericksen ZS, Macon WR, Slager SL, Call TG, Habermann TM, Cerhan JR. Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma. J Nutr. 2013 May; 143(5):672-81. Epub 2013 Mar 13.
    View PubMed
  11. Greenberg AJ, Lee AM, Serie DJ, McDonnell SK, Cerhan JR, Liebow M, Larson DR, Colby CL, Norman AD, Kyle RA, Kumar S, Rajkumar SV, Diasio RB, Slager SL, Vachon CM. Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma. Leukemia. 2013 Feb; 27(2):515-6. Epub 2012 Aug 16
    View PubMed
  12. Kelly JL, Fredericksen ZS, Liebow M, Shanafelt TD, Thompson CA, Call TG, Habermann TM, Macon WR, Wang AH, Slager SL, Cerhan JR. The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol. 2012 Dec; 22(12):855-62. Epub 2012 Nov 10.
    View PubMed
  13. Cerhan JR, Fredericksen ZS, Novak AJ, Ansell SM, Kay NE, Liebow M, Dogan A, Cunningham JM, Wang AH, Witzig TE, Habermann TM, Asmann YW, Slager SL. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1799-806. Epub 2012 Aug 21.
    View PubMed
  14. Holtan SG, O'Connor HM, Fredericksen ZS, Liebow M, Thompson CA, Macon WR, Micallef IN, Wang AH, Slager SL, Habermann TM, Call TG, Cerhan JR. Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma. Int J Cancer. 2012 Sep 1; 131(5):1158-68. Epub 2011 Nov 30.
    View PubMed
  15. Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, Shanafelt TD, Feldman AL, Ansell SM, Macon WR, Herr MM, Wang AH, Nowakowski GS, Call TG, Habermann TM, Slager SL, Witzig TE, Cerhan JR. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2012 Jul; 23(7):1017-29. Epub 2012 Apr 28.
    View PubMed
  16. Weymiller A, Simonson G, Liebow M, Goodwin K, Taylor G. The Minnesota Diabetes Plan 2015: Stemming the tide on an epidemic and improving patient care. Minn Med. 2011 Aug; 94(8):47-9.
    View PubMed
  17. Cerhan JR, Fredericksen ZS, Wang AH, Habermann TM, Kay NE, Macon WR, Cunningham JM, Shanafelt TD, Ansell SM, Call TG, Witzig TE, Slager SL, Liebow M. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet. 2011; 2(2):95-113. Epub 2011 Apr 05.
    View PubMed
  18. Kelly JL, Novak AJ, Fredericksen ZS, Liebow M, Ansell SM, Dogan A, Wang AH, Witzig TE, Call TG, Kay NE, Habermann TM, Slager SL, Cerhan JR. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2847-58. Epub 2010 Sep 20.
    View PubMed
  19. Elkin PL, Liebow M, Bauer BA, Chaliki S, Wahner-Roedler D, Bundrick J, Lee M, Brown SH, Froehling D, Bailey K, Famiglietti K, Kim R, Hoffer E, Feldman M, Barnett GO. The introduction of a diagnostic decision support system (DXplain) into the workflow of a teaching hospital service can decrease the cost of service for diagnostically challenging Diagnostic Related Groups (DRGs). Int J Med Inform. 2010 Nov; 79(11):772-7. Epub 2010 Oct 14.
    View PubMed
  20. White KL, Sellers TA, Fridley BL, Vierkant RA, Phelan CM, Tsai YY, Kalli KR, Berchuck A, Iversen ES, Hartmann LC, Liebow M, Armasu S, Fredericksen Z, Larson MC, Duggan D, Couch FJ, Schildkraut JM, Cunningham JM, Goode EL. Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer. Twin Res Hum Genet. 2010 Feb; 13(1):43-56.
    View PubMed
  21. Peedicayil A, Vierkant RA, Hartmann LC, Fridley BL, Fredericksen ZS, White KL, Elliott EA, Phelan CM, Tsai YY, Berchuck A, Iversen ES Jr, Couch FJ, Peethamabaran P, Larson MC, Kalli KR, Kosel ML, Shridhar V, Rider DN, Liebow M, Cunningham JM, Schildkraut Risk of ovarian cancer and inherited variants in relapse-associated genes. PLoS One. 2010; 5(1):e8884. Epub 2010 Jan 27.
    View PubMed
  22. Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Berchuck A, Couch FJ, Wang X, Fridley BL, Ovarian Cancer Association Consortium, Gentry-Maharaj A, Menon U, Hogdall E, Kjaer S, Whittemore A, DiCioccio R, Song H, Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer. 2009 Oct 20; 101(8):1461-8. Epub 2009 Sep 08.
    View PubMed
  23. Cerhan JR, Novak AJ, Fredericksen ZS, Wang AH, Liebow M, Call TG, Dogan A, Witzig TE, Ansell SM, Habermann TM, Kay NE, Slager SL. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. Br J Haematol. 2009 Jun; 145(5):614-23. Epub 2009 Mar 30.
    View PubMed
  24. Novak AJ, Slager SL, Fredericksen ZS, Wang AH, Manske MM, Ziesmer S, Liebow M, Macon WR, Dillon SR, Witzig TE, Cerhan JR, Ansell SM. Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. Cancer Res. 2009 May 15; 69(10):4217-24. Epub 2009 Apr 21.
    View PubMed
  25. Lubinski C, Aberg J, Bardeguez AD, Elion R, Emmanuel P, Kuritzkes D, Saag M, Squires KE, Weddle A, Rainey J, Zerehi MR, Ralston JF, Fleming DA, Bronson D, Cooke M, Cutler C, Ejnes Y, Gluckman R, Liebow M, Musana K, Mayer ME, Purtle MW, Reynolds PP, HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians. Clin Infect Dis. 2009 May 15; 48(10):1335-44.
    View PubMed
  26. White KL, Vierkant RA, Phelan CM, Fridley BL, Anderson S, Knutson KL, Schildkraut JM, Cunningham JM, Kelemen LE, Pankratz VS, Rider DN, Liebow M, Hartmann LC, Sellers TA, Goode EL. Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer. BMC Cancer. 2009; 9:170. Epub 2009 Jun 06.
    View PubMed
  27. Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3161-9.
    View PubMed
  28. Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PD, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cra Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer. 2008 Jul 15; 123(2):380-8.
    View PubMed
  29. Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, Pankratz VS, Fredericksen ZS, Gadre MK, Rider DN, Liebow M, Goode EL. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res. 2008 Apr 1; 68(7):2498-506.
    View PubMed
  30. Sellers TA, Huang Y, Cunningham J, Goode EL, Sutphen R, Vierkant RA, Kelemen LE, Fredericksen ZS, Liebow M, Pankratz VS, Hartmann LC, Myer J, Iversen ES Jr, Schildkraut JM, Phelan C. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):397-404.
    View PubMed
  31. Elkin PL, Brown SH, Balas A, Temesgen Z, Wahner-Roedler D, Froehling D, Liebow M, Trusko B, Rosenbloom ST, Poland G. Biosurveillance evaluation of SNOMED CT's terminology (BEST Trial): coverage of chief complaints. Stud Health Technol Inform. 2008; 136:797-802.
    View PubMed
  32. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares W, Macon WR, Jelinek D, Witzig TE, Habermann TM, Slager SL. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood. 2007 Dec 15; 110(13):4455-63. Epub 2007 Sep 07.
    View PubMed
  33. Slager SL, Kay NE, Fredericksen ZS, Wang AH, Liebow M, Cunningham JM, Vachon CM, Call TG, Cerhan JR. Susceptibility genes and B-chronic lymphocytic leukaemia. Br J Haematol. 2007 Dec; 139(5):762-71.
    View PubMed
  34. Sellers TA, Schildkraut JM, Pankratz VS, Vierkant RA, Fredericksen ZS, Olson JE, Cunningham J, Taylor W, Liebow M, McPherson C, Hartmann LC, Pal T, Adjei AA. Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005 Nov; 14(11 Pt 1):2536-43.
    View PubMed
  35. Liebow M. What will the new medicare drug benefit mean for Minnesota physicians? Minn Med. 2005 Mar; 88(3):38-41.
    View PubMed
  36. Liebow M. Dr. Liebow or Mr. Liebling? Minn Med. 2004 Oct; 87(10):31, 51.
    View PubMed
  37. Rich EO, Liebow M, Srinivason M, Parish D, Wolliscroft JO, Fein O, Blaser R. Medicare financing of graduate medical education - Intractable problems, elusive solutions. J Gen Intern Med. 2002 Apr; 17(4):283-92.
    View PubMed
  38. Harewood GC, Wiersema MJ, Edell ES, Liebow M. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy. Mayo Clin Proc. 2002 Feb; 77(2):155-64.
    View PubMed
  39. Liebow M. The Clinton Health Plan: A Slightly Informed Speculation Saint Francis Medical Proceedings. 1993; 3(3):7-9.
  40. Liebow M. Practice guidelines: wave of the future? Saint Francis Medical Proceedings. 1991; 2(1):11-2.
  41. Yang GJC, Liebow M. Chemotherapy for metastatic non-small cell carcinoma Saint Francis Medical Proceedings. 1990; 1(2):14-5.